Cargando…
The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype
INTRODUCTION: Exacerbations of COPD (ECOPDs) are important events in the course of COPD, accelerating the rate of decline in lung function and increasing the mortality risk. A growing body of evidence suggests the significance of the “frequent exacerbator” phenotype. This phenotype seems to be assoc...
Autores principales: | Miłkowska-Dymanowska, Joanna, Białas, Adam J, Szewczyk, Karolina, Kurmanowska, Zofia, Górski, Paweł, Piotrowski, Wojciech J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276626/ https://www.ncbi.nlm.nih.gov/pubmed/30568439 http://dx.doi.org/10.2147/COPD.S186170 |
Ejemplares similares
-
Eosinopenia and neutrophil-to-lymphocyte count ratio as prognostic factors in exacerbation of COPD
por: Karauda, Tomasz, et al.
Publicado: (2021) -
Geroprotectors as a therapeutic strategy for COPD – where are we now?
por: Miłkowska-Dymanowska, Joanna, et al.
Publicado: (2017) -
Epithelial Alarmins in Serum and Exhaled Breath in Patients with Idiopathic Pulmonary Fibrosis: A Prospective One-Year Follow-Up Cohort Study
por: Majewski, Sebastian, et al.
Publicado: (2019) -
Morphometric analysis of mitochondria in lymphocytes of patients with exacerbations of chronic obstructive pulmonary disease – pilot study
por: Białas, Adam J, et al.
Publicado: (2018) -
Serial Measurements of Circulating KL-6, SP-D, MMP-7, CA19-9, CA-125, CCL18, and Periostin in Patients with Idiopathic Pulmonary Fibrosis Receiving Antifibrotic Therapy: An Exploratory Study
por: Majewski, Sebastian, et al.
Publicado: (2021)